Gene therapy for respiratory diseases; progress and a changing context
The UK Respiratory Gene Therapy Consortium (GTC) The GTC was formed in 2001 from three groups at the Universities of Edinburgh and Oxford and Imperial College, London to explore gene therapy as a therapeutic option for people with cystic fibrosis (CF)1. The gene responsible for CF, Cystic Fibrosis T...
Main Authors: | Alton, EWFW, Boyd, AC, Davies, JC, Griesenbach, U, Gill, DR, Harman, TE, Hyde, SC, McLachlan, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Mary Ann Liebert
2020
|
Similar Items
-
Towards a first-in-human trial with a pseudotyped lentivirus
by: Alton, EW, et al.
Published: (2020) -
Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment
by: Sinadinos, A, et al.
Published: (2021) -
Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
by: Hyde, S, et al.
Published: (2015) -
Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
by: Sergijenko, A, et al.
Published: (2021) -
TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
by: Griesenbach, U, et al.
Published: (2011)